Notoginsenoside R1 suppresses miR-301a via NF-κB pathway in lipopolysaccharide-treated ATDC5 cells (Retracted article. See vol. 126, 2022)
Notoginsenoside R1 suppresses miR-301a via NF-κB pathway in lipopolysaccharide-treated ATDC5 cells (Retracted article. See vol. 126, 2022)
复制标题
DOI:
10.1016/j.yexmp.2019.104355
复制
发表时间:
2020-02-01
影响因子:
3.6
通讯作者:
Zhang, Lei
中科院分区:
文献类型:
--
作者:
Dong, Yan;Yan, Xia;Zhang, Lei
Background: Notoginsenoside R1 (NG-R1) exhibits a pharmacological activity against excessive inflammation. Here, we aimed to ascertain the anti-inflammatory role of NG-R1 in ankylosing spondylitis (AS) as well as the possible mechanism which is still under to be elucidated.Methods: In this study, lipopolysaccharide (LPS) was applied to evoke extreme inflammation in ATDC5 cells. To investigate the anti-inflammatory property of NG-R1, ATDC5 cells were exposed to NG-R1 prior to LPS stimulation. microRNA-301a (miR-301a)-overexpressed ATDC5 cells were established which confirmed by qRT-PCR. Then, inflammatory lesions were indicated by cell viability, apoptosis and inflammatory factors, including interleukin-1 beta (IL-1 beta), IL-6 and tumor necrosis factor-alpha (TNF-alpha). Nuclear factor-kappa B (NF-kappa B) pathway was determined by Western blotting assay.Results: We found NG-R1 dramatically dampened the decrease of cell viability, facilitation of apoptosis and abundance of inflammatory factors induced by LPS. Additionally, NG-R1 pre-incubation impeded LPS-induced accumulation of miR-301a. However, the protective capacity of NG-R1 was impaired by miR-301a overexpression. Of note, LPS-caused phosphorylation of p65 and inhibitor of nuclear factor kappa-B alpha (I kappa B alpha) was repressed by NG-R1, while further enhanced in miR-301-transfected ATDC5 cells.Conclusion: NG-R1 relived LPS-elicited inflammatory damages via blocking NF-kappa B in a miR-301a-silenced manner.